Ensysce Biosciences (ENSCW) Net Margin (2020 - 2025)
Historic Net Margin for Ensysce Biosciences (ENSCW) over the last 6 years, with Q3 2025 value amounting to 756.26%.
- Ensysce Biosciences' Net Margin fell 7756100.0% to 756.26% in Q3 2025 from the same period last year, while for Sep 2025 it was 244.49%, marking a year-over-year decrease of 652000.0%. This contributed to the annual value of 153.3% for FY2024, which is 3230900.0% up from last year.
- Ensysce Biosciences' Net Margin amounted to 756.26% in Q3 2025, which was down 7756100.0% from 126.39% recorded in Q2 2025.
- Over the past 5 years, Ensysce Biosciences' Net Margin peaked at 19.36% during Q3 2024, and registered a low of 3855.62% during Q2 2022.
- For the 5-year period, Ensysce Biosciences' Net Margin averaged around 849.65%, with its median value being 455.88% (2023).
- As far as peak fluctuations go, Ensysce Biosciences' Net Margin tumbled by -36451500bps in 2022, and later surged by 33997400bps in 2023.
- Ensysce Biosciences' Net Margin (Quarter) stood at 662.88% in 2021, then skyrocketed by 42bps to 385.21% in 2022, then tumbled by -77bps to 680.4% in 2023, then skyrocketed by 60bps to 273.42% in 2024, then tumbled by -177bps to 756.26% in 2025.
- Its last three reported values are 756.26% in Q3 2025, 126.39% for Q2 2025, and 147.42% during Q1 2025.